NeuronIcon Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
3
NeuronIcon General Information
Description
Developer of receptor technologies intended to treat neurological disorders. The company offers therapies for the treatment of brain damage and other brain-related diseases such as stroke, spinal cord injuries, and Alzheimer's and Parkinson's diseases, thereby enabling clinicians to effectively treat neurological disorders.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- Åbogade 15
- 8200 Aarhus
- Denmark
NeuronIcon Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NeuronIcon Patents
NeuronIcon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2283365-A2 | Design and use of sortilin specific molecular imaging ligands | Inactive | 27-Apr-2008 | 000000000 | |
| US-20110166032-A1 | Design and use of sortilin specific molecular imaging ligands | Inactive | 27-Apr-2008 | 000000000 |